Health Care/Hospital
OcuMension acquires rights to Alcon eye drops in exchange for a 16.7% equity stake, signaling the commencement of comprehensive strategic relationship
SHANGHAI, Aug. 12, 2024 /PRNewswire/ -- On August 13th 2024, Ocumension Therapeutics ("OcuMension") announced an agreement with Alcon Inc. ("Alcon", and collectively with OcuMension, the "Parties") where OcuMension will acquire or secure commercialization rights inChina to a portfolio of Alcon dr...
2024-08-12 22:01
2510
Momcozy's Ongoing Campaign for Breastfeeding Awareness Month Connects Moms and Breaks Barriers
NEW YORK, Aug. 12, 2024 /PRNewswire/ -- During Breastfeeding Awareness Month,
global mother and baby brandMomcozy
2024-08-12 22:00
1215
Mabwell's Novel Nectin-4 Targeting ADC 9MW2821 Granted Breakthrough Therapy Designation by China's NMPA
SHANGHAI, Aug. 12, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel Nectin-4 targeting ADC (R&D code: 9MW2821) has been granted Breakthrough Therapy Designation (BTD) bythe Center for Drug Evaluation (CDE) of China's...
2024-08-12 22:00
1934
Ocumension (01477.HK) Demonstrates Strong Operational Resilience, Commercialization Capabilities Reach New Heights
SHANGHAI, Aug. 12, 2024 /PRNewswire/ -- On August 12, Ocumension Therapeutics ( Shanghai) Co., Ltd. (01477.HK, hereinafter referred to as "Ocumension" or the "Company") released its 2024 Interim Results Report. During the reporting period, the company achieved operating revenue ofRMB 168 million, ...
2024-08-12 21:52
3033
Xiao-I Corporation Showcases Hearview Smart Glasses at Successful U.S. Launch Event
SHANGHAI, Aug. 12, 2024 /PRNewswire/ -- Xiao-I Corporation ("Xiao-I" or the "Company") (NASDAQ: AIXI), a leading artificial intelligence company, is proud to announce the successful U.S. launch of its innovative Hearview Smart Glasses. The event, which was streamed live on YouTube onAugust 8th at...
2024-08-12 21:30
2892
VISEN Pharmaceuticals announced that the Phase 3 PaTHway China Trial of Palopegteriparatide achieved primary and key secondary endpoints in the treatment of adults with hypoparathyroidism
* 77.6% of patients treated with palopegteriparatide in the PaTHway China Trial achieved the primarymulti-component endpoint compared to 0.0% for placebo (p <0.0001) * Palopegteriparatide was generally safe and well-tolerated, with no discontinuations related to study drug. SHANGHAI, Aug. 12...
2024-08-12 21:00
1810
Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial
There was a clinically meaningful and persistent improvement depression measured by the key secondary endpoint of MADRS.[1] The primary endpoint of superiority to placebo in a cognitive "attention composite" of three Cogstate computerized tests was not met with large improvements seen in both Xan...
2024-08-12 20:30
1833
AXA Study: Hong Kong workers buckling under high stress and poor mind health
More than 3 in 4 Hong Kong workers face mind health issues at work, with nearly half taking sick leave HONG KONG, Aug. 12, 2024 /PRNewswire/ -- The majority of the working population inHong Kong suffers from multiple mental health problems related to work, and disengagement is alarmingly high, a...
2024-08-12 18:19
2139
FEELING FOGGY, DISTRACTED, DEMOTIVATED? DON'T LET BRAIN FATIGUE HOLD YOU BACK
* Brain fatigue causes symptoms like forgetfulness and difficulty concentrating. * BRAND'S® Essence of Chicken unlocks the crucial link between diet and brain fatigue, highlighting the importance of amino acids for brain health. KUALA LUMPUR, Malaysia, Aug. 12, 2024 /PRNewswire/ -- Have you e...
2024-08-12 16:00
1638
Sumedang Regency and Docquity Launch AI-Driven Health Platform to Tackle Tuberculosis, Stunting, and Hypertension
SUMEDANG, Indonesia, Aug. 12, 2024 /PRNewswire/ -- Docquity, a leading health tech company established in 2015, is proud to announce its expansion into the B2G sector with the launch of the Puskesmas AI platform in partnership with Sumedang Regency,West Java. This initiative builds on the success...
2024-08-12 15:00
1867
Milestone: Renal Nerve Mapping / Selective Renal Denervation (msRDN) System by SyMap Medical Ltd Approved for Treatment of Uncontrolled Hypertension in China
SUZHOU, China, Aug. 12, 2024 /PRNewswire/ -- On August 6, 2024, the msRDN System (SyMapCath I®/ SYMPIONEER S1®), developed by Suzhou/China-based SyMap Medical Ltd. (SyMap Medical), was approved by the National Medical Products Administration (NMPA) ofChina and granted a Class III Medical Devices ...
2024-08-12 13:55
1368
IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Two New Autoimmune Disease Indications
SHANGHAI, NANJING, China and SAN JOSE, Calif., Aug. 12, 2024 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, today announced that the investigation...
2024-08-12 13:52
1440
German Stem Cell Expert Leads Delegation to Boost Sino-German Health & Educational Cooperation
BAODING, China, Aug. 12, 2024 /PRNewswire/ -- A landmark German delegation, led by world-renowned stem cell expert Prof. Dato' Sri Dr.Mike Chan, concluded a three-day visit to Baoding,China, marking a significant step in international health cooperation. The visit, fromJuly 11-13, reciprocated an...
2024-08-12 12:08
1881
The San Ignacio Hospital project in Peru was officially handed over
BEIJING, Aug. 11, 2024 /PRNewswire/ -- On 1 August local time, the San Ignacio Hospital project inPeru, constructed by POWERCHINA, successfully passed the final acceptance of the owner and obtained the official handover certificate. This project is the first hospital project formally handed over ...
2024-08-12 10:55
2383
Hong Kong Breast Cancer Foundation charity walk "Pink Walk 2024" - "Walk for Breast Cancer, Together We Can"
20 October at The Peak HONG KONG, Aug. 12, 2024 /PRNewswire/ -- The Hong Kong Breast Cancer Foundation (HKBCF), is delighted to announce that its annual signature fundraising event"Pink Walk 2024" will take place on 20 October 2024 (Sunday) at The Peak,Hong Kong Island. Themed "Walk for Breast C...
2024-08-12 10:45
1630
Alphamab Oncology to Present the Latest Clinical Data of Anti-HER2 Bispecific ADC JSKN003 at the ESMO Congress 2024
SUZHOU, China, Aug. 12, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from two studies on anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 in patients with platinum-resistant ovarian cancer and patients with advanced HER2-positive (...
2024-08-12 10:18
1837
AsiaMedic launches customised AI virtual assistantwith Enterprise SG affiliated startup MIEA Health
* WhatsApp integrated AI virtual assistant expected to reduce call handling time, enabling AsiaMedic to serve its customers more efficiently and effectively. SINGAPORE, Aug. 12, 2024 /PRNewswire/ -- SGX Catalist-listed AsiaMedic Limited (the "Company" and together with its subsidiaries, the "Gr...
2024-08-12 06:00
2247
GenScript Biotech Reports First Half 2024 Results
Strong Revenue Growth and Strategic Advances Across Key Segments, Enhances Commitment to ESG and Sustainable Development * Impressive Financial Growth: The group reported a 43.5% increase in revenue, driven by a 156% boost in cell therapy revenue and a 75.4% rise in gross profit, showcasing s...
2024-08-09 23:19
3750
Pulnovo Medical Announces First Enrollment in Singapore for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease
SHANGHAI, Aug. 9, 2024 /PRNewswire/ -- Pulnovo Medical Limited,a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the launch ofAsia's first international multi-center clinical study of Percutaneous Pulmonary Artery ...
2024-08-09 17:09
4789
Innovative Anti-Nausea Smartwatch EmeTerm® Smart Set to Launch on Indiegogo
VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ -- EmeTerm® Smart uses patented hybrid technology to seamlessly integrate the functionality of a smartwatch with that of an anti-nausea wristband, ensuring a carefree and healthy life for all. EmeTerm® Smart is launching on Indiegogo as the world's first a...
2024-08-08 23:00
1634
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5902
